Insufficient scRNA-seq data for expression of PRR19 at single-cell level.
Insufficient scRNA-seq data for expression of PRR19 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| brain | 99% | 134.22 | 2614 / 2642 | 97% | 3.12 | 682 / 705 |
| ovary | 89% | 32.52 | 161 / 180 | 100% | 4.46 | 428 / 430 |
| prostate | 96% | 50.99 | 234 / 245 | 93% | 2.16 | 465 / 502 |
| uterus | 88% | 37.42 | 150 / 170 | 98% | 4.49 | 448 / 459 |
| breast | 86% | 34.25 | 395 / 459 | 97% | 3.91 | 1087 / 1118 |
| bladder | 90% | 25.52 | 19 / 21 | 90% | 3.06 | 455 / 504 |
| skin | 89% | 30.55 | 1612 / 1809 | 89% | 4.07 | 421 / 472 |
| thymus | 96% | 32.30 | 628 / 653 | 70% | 1.19 | 421 / 605 |
| intestine | 89% | 28.42 | 864 / 966 | 72% | 1.46 | 379 / 527 |
| lung | 74% | 23.70 | 426 / 578 | 81% | 2.47 | 931 / 1155 |
| esophagus | 82% | 35.96 | 1183 / 1445 | 72% | 2.12 | 132 / 183 |
| stomach | 73% | 18.05 | 263 / 359 | 74% | 1.94 | 212 / 286 |
| adrenal gland | 100% | 68.96 | 257 / 258 | 43% | 0.99 | 98 / 230 |
| kidney | 94% | 39.40 | 84 / 89 | 14% | 0.29 | 122 / 901 |
| liver | 66% | 20.11 | 150 / 226 | 40% | 1.55 | 161 / 406 |
| ureter | 0% | 0 | 0 / 0 | 100% | 2.87 | 1 / 1 |
| pancreas | 57% | 11.88 | 188 / 328 | 42% | 0.83 | 74 / 178 |
| spleen | 96% | 36.80 | 232 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 96% | 5.12 | 43 / 45 |
| adipose | 75% | 20.02 | 904 / 1204 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 69% | 1.07 | 55 / 80 |
| peripheral blood | 45% | 10.33 | 417 / 929 | 0% | 0 | 0 / 0 |
| muscle | 40% | 8.23 | 319 / 803 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 38% | 1.17 | 11 / 29 |
| heart | 33% | 6.12 | 280 / 861 | 0% | 0 | 0 / 0 |
| blood vessel | 20% | 4.10 | 267 / 1335 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0051321 | Biological process | meiotic cell cycle |
| GO_0005694 | Cellular component | chromosome |
| GO_0005634 | Cellular component | nucleus |
| GO_0005515 | Molecular function | protein binding |
| Gene name | PRR19 |
| Protein name | Proline-rich protein 19 |
| Synonyms | |
| Description | FUNCTION: Promotes meiotic crossing over formation through its interaction with CNTD1 by participating in the crossover differentiation step of crossover-specific recombination intermediates. . |
| Accessions | ENST00000341747.8 [A6NJB7-1] A6NJB7 M0QXP7 ENST00000598490.1 [A6NJB7-2] ENST00000499536.2 [A6NJB7-1] ENST00000595750 ENST00000595750.2 [A6NJB7-1] |